Position: Home > Products > Principal Products Principal Products
  • Cardio-cerebral

    Cardio-cerebral medicines are manufactured mainly by Beijing Tide and NJCTT and accounted for approximately 16.5% of the Group’s turnover. The category's major product Kaishi injections produced by Beijing Tide works on the Drug Delivery System (DDS) theory to improve cardio-cerebral micro-circulation blockage. [View]

  • Hepatitis

    Hepatitis medicines is one of JCTT’s main product series which recorded sales of approximately HK$3,827.35 million for the year ended 31 December, 2012 and accounted for approximately 46% of the Group’s turnover. [View]

  • Oncology

    Tianqingyitai injections, Tianqingrian injections, Zhiruo injections and Renyi injections are mainly developed and manufactured by JCTT and NJCTT. For the year ended 31 December, 2012, sales of oncology medicines amounted to approximately HK$613.12 million, a remarkable increase of approximately 41.9% as compared with the same period last year. [View]

  • Analgesic

    Launched in 2005, the analgesic medicine Kaifen injections is developed and manufactured by Beijing Tide. It is a Flurbiprofen Axetil microsphere target sustained release analgesic injection produced based on the DDS theory and enabled by advanced target technology. The product is famous for strong pain relieving effect with minimal side effects and has... [View]